Senator Kirkmeyer, primary bill sponsor, introduced Senate Bill 26-099, which gives the Governor the authority to declare a material, compound, mixture, or preparation an analog of a schedule II drug if the substance is substantially similar to the chemical structure of a schedule II drug or was designed to produce similar or greater effects, and the Governor issues an executive order that provides reasonable notice to the public and the General Assembly, and provides a designation date for when the analog is a schedule II drug. The designation is only effective for two years and may be repealed earlier; however, it cannot be extended or renewed. The bill does not prohibit the courts from finding a substance an analog of a schedule II drug and the General Assembly may terminate the designation through a Joint Resolution.

Committee members provided closing remarks.